Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Primary sclerosing cholangitis].

M Molina Jurado, J Ferrer, N Gómez

    Acta Gastroenterologica Latinoamericana
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Primary Sclerosing Cholangitis (PSC) is a rare liver disease with unknown causes. It involves severe inflammation and fibrosis of the bile ducts within and outside the liver.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A phase II, multicenter, open-label, single-arm study of berzosertib plus topotecan in patients with relapsed platinum-resistant small-cell lung cancer (DDRiver SCLC 250).

    ESMO open·2025
    Same author

    Development and evaluation of the phenotypic 2G test to detect drug-resistant TB.

    IJTLD open·2025
    Same author

    Genetic architecture of oral glucose-stimulated insulin release provides biological insights into type 2 diabetes aetiology.

    Nature metabolism·2024
    Same author

    Metabolic and productive adaptive response of beef cows to successive short-nutritional challenges.

    Research in veterinary science·2024
    Same author

    The xenobiotic transporter <i>ABCC4</i>/MRP4 promotes epithelial mesenchymal transition in pancreatic cancer.

    Frontiers in pharmacology·2024
    Same author

    A novel algorithm for optimizing hydrocyclone operations in the decontamination of potentially toxic elements in soils.

    Chemosphere·2024
    Same journal

    [Solid Pseudopapillary Neoplasm of the Pancreas: Diagnosis and Surgical Management in a Young Patient].

    Acta gastroenterologica Latinoamericana·2026
    Same journal

    Small Intestinal Bacterial Overgrowth and Intestinal Methanogen Overgrowth: Are They Overdiagnosed?

    Acta gastroenterologica Latinoamericana·2026
    Same journal

    Pancreatic Atypical Neurofibromatous Neoplasm with Uncertain Biological Potential (ANNUBP) Mimicking a Solid Pseudopapillary Tumor Pancreatic ANNUBP.

    Acta gastroenterologica Latinoamericana·2026
    Same journal

    [Prevalence of Anxiety and Depression in Patients with Inflammatory Bowel Disease: Association with Disease Activity and its Impact on Quality of Life].

    Acta gastroenterologica Latinoamericana·2026
    Same journal

    Acta gastroenterologica Latinoamericana·2026
    Same journal

    [Use of Los Angeles Classification in Erosive Esophagitis: analysis of inter-observer and intra-observer agreement].

    Acta gastroenterologica Latinoamericana·2026
    See all related articles

    Area of Science:

    • Hepatology
    • Gastroenterology

    Background:

    • Primary Sclerosing Cholangitis (PSC) is a rare, chronic liver disease.
    • The exact etiology of PSC remains unknown.
    • PSC is characterized by inflammation and fibrosis of the intrahepatic and extrahepatic biliary tree.

    Observation:

    • PSC involves progressive damage to the bile ducts.
    • Fibrosis can lead to bile duct strictures and obstruction.
    • This can result in liver damage and complications.

    Findings:

    • The study focuses on the pathological characteristics of PSC.
    • Key features include intense inflammation and fibrotic changes.
    • These changes affect both intrahepatic and extrahepatic bile ducts.

    Related Experiment Videos

    Implications:

    • Understanding PSC's pathology is crucial for diagnosis and management.
    • Further research into PSC etiology may reveal therapeutic targets.
    • Improved knowledge can aid in managing complications associated with bile duct fibrosis.